CP 55,244: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== CP-55,244 == | |||
[[File:CP-55,244.svg|thumb|right|Chemical structure of CP-55,244]] | |||
CP 55,244 is a | '''CP-55,244''' is a synthetic cannabinoid compound that acts as a potent agonist of the [[cannabinoid receptor]]s. It is primarily used in scientific research to study the [[endocannabinoid system]] and its effects on various physiological processes. | ||
== | == Chemical Properties == | ||
CP-55,244 is a member of the [[cannabinoid]] class of compounds, which are known for their interaction with the cannabinoid receptors in the [[central nervous system]]. The chemical structure of CP-55,244 is characterized by its complex arrangement of carbon, hydrogen, and oxygen atoms, as depicted in the adjacent image. | |||
== Mechanism of Action == | |||
CP-55,244 functions as an agonist at the [[CB1 receptor|CB1]] and [[CB2 receptor|CB2]] cannabinoid receptors. These receptors are part of the [[G protein-coupled receptor]] family and are involved in a variety of physiological processes, including [[pain modulation]], [[appetite regulation]], and [[immune response]]. | |||
== Pharmacological Effects == | |||
The activation of cannabinoid receptors by CP-55,244 leads to a range of effects, which can include alterations in [[neurotransmitter]] release, modulation of [[inflammatory response]], and changes in [[behavioral patterns]]. Due to its potency, CP-55,244 is often used in laboratory settings to explore the potential therapeutic applications of cannabinoid receptor modulation. | |||
== | == Research Applications == | ||
CP-55,244 is utilized in [[preclinical research]] to investigate the role of the endocannabinoid system in various diseases and conditions. Studies often focus on its potential in treating [[neuropathic pain]], [[anxiety disorders]], and [[neurodegenerative diseases]]. | |||
== Safety and Toxicology == | |||
As with many synthetic cannabinoids, the safety profile of CP-55,244 is not fully understood. Research is ongoing to determine its potential [[toxicological]] effects and any long-term consequences of its use in experimental settings. | |||
== Related Pages == | |||
* [[Cannabinoid receptor]] | * [[Cannabinoid receptor]] | ||
* [[Endocannabinoid system]] | * [[Endocannabinoid system]] | ||
* [[ | * [[Synthetic cannabinoids]] | ||
* [[ | * [[CB1 receptor]] | ||
* [[CB2 receptor]] | |||
[[Category:Synthetic cannabinoids]] | [[Category:Synthetic cannabinoids]] | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
Latest revision as of 03:54, 13 February 2025
CP-55,244[edit]
CP-55,244 is a synthetic cannabinoid compound that acts as a potent agonist of the cannabinoid receptors. It is primarily used in scientific research to study the endocannabinoid system and its effects on various physiological processes.
Chemical Properties[edit]
CP-55,244 is a member of the cannabinoid class of compounds, which are known for their interaction with the cannabinoid receptors in the central nervous system. The chemical structure of CP-55,244 is characterized by its complex arrangement of carbon, hydrogen, and oxygen atoms, as depicted in the adjacent image.
Mechanism of Action[edit]
CP-55,244 functions as an agonist at the CB1 and CB2 cannabinoid receptors. These receptors are part of the G protein-coupled receptor family and are involved in a variety of physiological processes, including pain modulation, appetite regulation, and immune response.
Pharmacological Effects[edit]
The activation of cannabinoid receptors by CP-55,244 leads to a range of effects, which can include alterations in neurotransmitter release, modulation of inflammatory response, and changes in behavioral patterns. Due to its potency, CP-55,244 is often used in laboratory settings to explore the potential therapeutic applications of cannabinoid receptor modulation.
Research Applications[edit]
CP-55,244 is utilized in preclinical research to investigate the role of the endocannabinoid system in various diseases and conditions. Studies often focus on its potential in treating neuropathic pain, anxiety disorders, and neurodegenerative diseases.
Safety and Toxicology[edit]
As with many synthetic cannabinoids, the safety profile of CP-55,244 is not fully understood. Research is ongoing to determine its potential toxicological effects and any long-term consequences of its use in experimental settings.
